Regulatory News In Brief
This article was originally published in The Gray Sheet
Executive Summary
Clinical trial improvement grants: FDA is awarding up to $1.5 million in grants in FY 2009 for projects aimed at improving the design and execution of clinical trials, the agency announces June 19. The grants program is part of the FDA/Duke Clinical Trials Transformation Initiative, a public-private effort to identify practices that will increase the quality and efficiency of clinical trials (1"The Gray Sheet" Feb. 9, 2009). Grants will support cooperative arrangements between FDA and outside researchers with qualifying projects. Grant applications are due July 6, and funds will be awarded around September
You may also be interested in...
Clinical Trials Reform Group Launches Study Monitoring Project
The FDA/Duke University Clinical Trials Transformation Initiative is rolling out a detailed 1plan for its first project, aimed at defining best practices for clinical trial monitoring in various settings
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.